Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Lenvatinib
Related studies linked through entity extraction aliases.
Intra-Tumoral Vascular Growth Patterns is a Robust Indicator of Adjuvant Therapy Following Liver Resection in HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC
- Status
- COMPLETED
- Phase
- N/A
Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model
- Status
- RECRUITING
- Phase
- PHASE2
Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
HAIC+Adebrelimab+Lenvatinib for Conversion Treatment of Potentially Resectable, Locally Advanced Biliary Tract Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
CARE1 Pragmatic Clinical Trial
- Status
- RECRUITING
- Phase
- PHASE3
Toripalimab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer
- Status
- RECRUITING
- Phase
- PHASE2
HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- N/A
Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)
- Status
- RECRUITING
- Phase
- PHASE2
Combination of SBRT, PD-L1 Inhibitor, and Lenvatinib in Hepatocellular Carcinoma (HSBRT2401)
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant Therapy of HAIC（GEMOX） Combined With Adebrelimab and Lenvatinib for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
- Status
- RECRUITING
- Phase
- PHASE2
FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial
- Status
- RECRUITING
- Phase
- PHASE3